The Wellness Process 85. The New Era of Health: Prevention, Biomarkers, AI & Peptides with Nate Graville
14 snips
Oct 28, 2025 Nate Graville, founder of Jevity and entrepreneur in proactive healthcare, shares his compelling journey inspired by losing his father to cancer. He discusses the critical importance of prevention, overlooked biomarkers, and how AI is revolutionizing personalized care. Nate critiques traditional medicine and Big Pharma's influence on education, advocating for a balanced approach that incorporates data-driven solutions. He also explains innovative uses of peptides in health strategies and the significance of tracking biological age for longevity.
AI Snips
Chapters
Transcript
Episode notes
Insurance Limits Create Blind Spots
- Standard primary care blood panels omit critical biomarkers like CRP, homocysteine, Lp(a) and ApoB because insurance dictates coverage.
- Missing these markers leaves serious blind spots for preventative and longevity-focused care.
How Funding Shapes Medical Knowledge
- Medical education and trials are heavily funded by big pharma, creating conflicts of interest that shape what is studied and taught.
- This skews research toward monetizable interventions and ignores many non-patentable therapies.
Living Meta-Analyses As New Evidence
- Companies can run living meta-analyses on real customers to generate evidence outside traditional pharma-funded trials.
- Aggregated, anonymized user data could accelerate validation of therapies like peptides at scale.